Keynote Speech 2025: Prof. Robert T. Schooley

Posted on by Targeting Phage Therapy
It is a great pleasure to welcome Prof. Robert Schooley, from University of California, San Diego (USA) as a key note speaker during Targeting Phage Therapy 2025, this June in Berlin.
 
He will present a talk on: Phage Therapy 2030: Getting from Here to There.
 
The use of phages in clinical medicine has been accelerating for nearly a decade and is poised to further accelerate over the foreseeable future. By 2030 it is likely that phage use will be substantially more widespread than at present. In his keynote speech, Prof. Schooley will speculate about where phage therapy we be in 2030 and what will it take to get there.
 
About Professor Robert T. Schooley
 
Robert T. Schooley, MD, is an infectious disease specialist and an expert in HIV and hepatitis C (HCV) infection and treatment. Infectious disease specialists care for patients with infections or diseases caused by viruses, bacteria, fungi and parasites. 

His research interests include influenza, global health and international medicine, and the diagnosis and management of infections that cause death and morbidity in resource-limited settings. Dr. Schooley is particularly interested in the origin and development (pathogenesis) of HIV and HIV therapy, and was one of the first researchers to describe the humoral and cellular immune responses to HIV infection.

Dr. Schooley is a professor in the Division of Infectious Diseases within the Department of Medicine at UC San Diego School of Medicine, where he has developed a multidisciplinary research program for hepatitis C.

He leads the Universidade Eduardo Mondlane-UC San Diego Medical Education Partnership Initiative and supervises postdoctoral fellows.

Dr. Schooley is extensively published, having edited numerous books and authored hundreds of articles and book chapters. He serves on the editorial board of several medical journals, including Journal of Acquired Immune Deficiency Syndromes and Clinical Infectious Diseases.

In 2013, Dr. Schooley was honored with the Best Doctors in America and America’s Top Doctors award.